Heterocyclic compounds containing the five-membered oxadiazole nucleus possess verity of biological activities. 1,3,4-oxadiazole moieties are important because of their versatile biological action. The present study depicts synthesis of some novel 2-(2-(cyclopropylmethoxy)phenyl)-5-methyl-1,3,4-oxadiazole was prepared from N'-acetyl-2-(cyclopropylmethoxy)benzohydrazide by using triphenylphosphine, triethylamine, carbon tetrachloride and acetonitrile at 100°C for 1h. The final compound was examined for its antibacterial activity.
INTROdUCTION
Compounds bearing oxadiazole moiety are of great importance Between five-membered heterocycles which have been recognized as privileged structures in medicinal chemistry. Four isomers of oxadiazoles are well-known which, amongst of them 1,3,4-oxadiazole nucleus is found in many therapeutic agents, such as Fenadiazole, Nesapidil, Furamizole, and Raltegravir ( Figure 1 ) [1] [2] [3] [4] . 1,3,4-oxadiazole derivatives exhibited a wide variety of biological activities such as antimicrobial, antimitotic, antihypertensive, anticonvulsant, antiinflammatory, and muscle relaxant [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . The valuable medicinal properties of 1,3,4-oxadiazole make these compounds an important structural unit to be the subject of extensive research in recent years. Therefore, development of new structures of 1,3,4-oxadiazole would be highly desirable.
The common methods used for the synthesis of 1,3,4-oxadiazoles involves the cyclization of the carboxylic acid hydrazides with a variety of dehydrating reagents such as POCl3, concentrated sulfuric acid, phosphonium salts and Burgess-type reagents.
Herein, we reported a five steps synthesis of 2-(2-(cyclopropylmethoxy)phenyl)-5-methyl-1,3,4-oxadiazole, starting from 2-hydroxybenzoic acid in good yield (Scheme 1). 
Reagents and Instrumentation
All reagents were purchased from Merck and Aldrich and used without further purification. The NMR spectra were recorded on a Bruker Avance DPX 400 MHz instrument. The spectra were measured in DMSO-d6 relative to TMS (0.00 ppm). Elemental analysis was performed on a Heraeus CHN-O-Rapid analyzer. TlC was performed on silica gel Polygram SIl G/UV 254 plates.
Experimental Procedure Preparation of ethyl 2-hydroxybenzoate
Thionyl chloride (20 ml, 0.275 mmol) was added dropwise to a stirred solution of salicylic acid (10 g, 0.0724 mmol) in ethanol (50 ml) at 0°C and the mixture was stirred for 12h at 80°C. After completion of starting material (TlC monitoring), the reaction mixture was concentrated to remove the unreacted thionyl chloride and ethanol under reduced pressure.
The residue was diluted with water and extracted with MTBE solvent . The organic layer was washed with an aqueous solution of NaHCO3 (10%), dried with sodium sulfate and concentrated under reduced pressure to obtain the pure product as a brown color liquid (Yield: 65% 
Preparation of 2-hydroxybenzohydrazide
Hydrazine monohydrate (20 ml) was added to a solution of ethyl 2-hydroxybenzoate (4 g, 0.024 mmol) in ethanol (100 ml) at room temperature and the reaction mixture was heated to 80°C and and stirred for 2h at same temperature. After completion of the reaction (TlC monitoring), ethanol was concentrated. To that residue ice cold water was added and stirred for 30 min until a white color solid was precipitated. The white solid was filtered and dried under vacuum (Yield 70%). .
Preparation of N'-acetyl-2-hydroxy benzo hydrazide
A mixture of 2-hydroxybenzohydrazide (2.5 g, 0.016 mmol) and acetic acid (25 ml) was heated to 80°C and stirred for 2h. After completion of the reaction (TlC monitoring), the mixture was poured into ice cold water and stirred for 15 min until a white color solid was precipitated. The solid was filtered and dried under vacuum (Yield 56%). 
Preparation of N'-acetyl-2-(cyclopropylmethoxy) benzohydrazide
To a s o l u t i o n o f N ' -a c e t y l -2 -hydroxybenzohydrazide (1 g, 0.0051 mmol) in acetonitrile: water (9:1) (10 ml) was added potassium carbonate (1. 
Preparation of 2-(2-(cyclopropylmethoxy) phenyl)-5-methyl-1,3,4-oxadiazole
To a s o l u t i o n o f N ' -a c e t y l -2 -(cyclopropylmethoxy)benzohydrazide (250 mg, 0.001 mmol) in acetonitrile (2.5 ml) was added a mixture of triphenylphosphine (341 mg, 0.0015 mmol), triethylamine (152 mg, 0.0015 mmol) and carbon tetrachloride (1.25 ml) under magnetic stirring. The reaction mixture was heated to 100°C and stirred Cpd -6 50 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 100 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 150 0.00 ± 0.00 10.00 ± 0.00 0.00 ± 0.00 10.00 ± 0.00 200 0.00 ± 0.00 10.67 ± 0.58 0.00 ± 0.00 10.33 ± 0.00 Gentamicin 10 16.00 ± 1.00 14.67 ± 0.58 15.67 ± 0.58 14.33 ± 0.58
Values are means of three independent analysis ± Standard Deviation (n=3) for 1h at same temperature. After completion (TlC monitoring), the reaction mixture was completely concentrated and the crude product was purified by column chromatography eluted by ethyl acetate/ hexane (5-10%) (Yield 52% 
Antibacterial activity
The in vitro antibacterial activity of 2-(2-(cyclopropylmethoxy)phenyl)-5-methyl-1,3,4-oxadiazole was analyzed by minimum inhibitory concentration (MIC) method. Escherichia coli and Klebsiella pneumonia as Gram negative bacteria and Staphylococcus aureus and Bacillus cereus as Gram positive bacteria were used to determine the antibacterial activity. Different concentrations of 50, 100, 150 and 200 ìg/ml of the sample in N,Ndimethyl formamide (DMF) were prepared in the test tubes. The lowest inhibitory concentration of the test compounds was determined by MIC method that shows the zone of inhibition after 18h. gentamicin was used as the standard drug in the assay
RESULTS ANd dISCUSSION
2-(2-(cyclopropylmethoxy)phenyl)-5-methyl-1,3,4-oxadiazole was prepared in good yield via a five step synthesis starting from 2-hydroxybenzoic acid (scheme 1). 2-Hydroxybenzohydrazide was synthesized in two first steps esterification followed by hydrazinolysis. N'-acetyl-2-hydroxybenzohydrazide Table 1 ).
In summary, 2-(2-(cyclopropylmethoxy) phenyl)-5-methyl-1,3,4-oxadiazole was successfully synthesized in five steps in good yield and was used for antibacterial activity against Gram-positive and Gram-negative bacteria. In comparison with Gentamicin, the compounds show relatively a good antibacterial activity.
